Soroosh Kiani, MD
Cardiovascular Disease · Worcester, MANPI 1669769279
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Boston Scientific at 41.6% of the total. Reporting peaked in 2019 at $3,988 and has fallen 95.4% since, to $185 in 2025.
Across 55 payments — averaging $158.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$3K
- Medtronic$2K
- Cardiva Medical, Inc.$44
- Cardiofocus, Inc.$16
Across 43 payments — averaging $1332.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$57K
What the payments were for
- Consulting fees$1,42516%
- Speaking & faculty fees$5006%
- Grants$90110%
- Travel & lodging$4,00046%
- Food & beverage$1,75020%
- Education$1572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $3,633 |
| Abbott | 15 | $2,917 |
| Medtronic(2 entities) | 21 | $2,123 |
| Cardiva Medical, Inc. | 3 | $44 |
| Cardiofocus, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,665
- Perclose ProGlide suture mediated closure system$1,425
- GENERAL TACHY$901
- GENERAL - THERAPIES$771
- AVEIR$724
- Micra$666
- ENSITE PRECISION$336
- Perclose ProStyle$185
- JETi Peripheral Catheter$110
How this compares
$8,733 in reported general payments places this provider in the 70th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 183 | $164,060 |
| XareltoRivaroxaban | 25 | $29,221 |
| Metoprolol Succinate | 91 | $2,002 |
| Flecainide Acetate | 13 | $1,363 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $628 |
| Atorvastatin Calcium | 31 | $536 |
| Carvedilol | 24 | $455 |
| Metoprolol Tartrate | 37 | $378 |
| Losartan Potassium | 21 | $369 |
| Amlodipine Besylate | 26 | $277 |
| Rosuvastatin Calcium | 11 | $227 |
| Amiodarone Hcl | 13 | $218 |
| Diltiazem Hcl | 11 | $194 |
| Spironolactone | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Worcester
- Bryon Gentile IiWorcester$235K
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- Kevin CroceChestnut Hill$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.